Thiolutin attenuates ischemic stroke injury via inhibition of NLRP3 inflammasome: an in vitro and in vivo study

[1]  R. Gottesman,et al.  Impact of Cerebral Autoregulation Monitoring in Cerebrovascular Disease: A Systematic Review , 2022, Neurocritical Care.

[2]  Canwen Liu,et al.  Astragaloside IV Alleviates Cerebral Ischemia-Reperfusion Injury through NLRP3 Inflammasome-Mediated Pyroptosis Inhibition via Activating Nrf2 , 2021, Oxidative medicine and cellular longevity.

[3]  Wei Zhang,et al.  ADAM8 Activates NLRP3 Inflammasome to Promote Cerebral Ischemia-Reperfusion Injury , 2021, Journal of healthcare engineering.

[4]  Yun Xu,et al.  γ-Glutamylcysteine Alleviates Ischemic Stroke-Induced Neuronal Apoptosis by Inhibiting ROS-Mediated Endoplasmic Reticulum Stress , 2021, Oxidative medicine and cellular longevity.

[5]  J. Heit,et al.  Reperfusion Therapies for Children With Arterial Ischemic Stroke , 2021, Topics in magnetic resonance imaging : TMRI.

[6]  Zongjian Liu,et al.  Curcumin Ameliorates White Matter Injury after Ischemic Stroke by Inhibiting Microglia/Macrophage Pyroptosis through NF-κB Suppression and NLRP3 Inflammasome Inhibition , 2021, Oxidative medicine and cellular longevity.

[7]  T. Kang,et al.  NLRP3 Ubiquitination—A New Approach to Target NLRP3 Inflammasome Activation , 2021, International journal of molecular sciences.

[8]  X. Xiong,et al.  Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition , 2021, Frontiers in Immunology.

[9]  Q. Zheng,et al.  Overexpression of TOLLIP Protects against Acute Kidney Injury after Paraquat Intoxication through Inhibiting NLRP3 Inflammasome Activation Modulated by Toll-Like Receptor 2/4 Signaling , 2021, Mediators of inflammation.

[10]  Bo Zhao,et al.  Relevant mediators involved in and therapies targeting the inflammatory response induced by activation of the NLRP3 inflammasome in ischemic stroke , 2021, Journal of neuroinflammation.

[11]  Khiany Mathias,et al.  NLRP3 inflammasome activation increases brain oxidative stress after transient global cerebral ischemia in rats , 2021, The International journal of neuroscience.

[12]  Chao Jing,et al.  The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation , 2021, Theranostics.

[13]  Yang Xiao,et al.  Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases , 2021, Science Immunology.

[14]  Chao Jing,et al.  Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness , 2021, Theranostics.

[15]  G. Stoll,et al.  The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice , 2020, Brain, Behavior, and Immunity.

[16]  Surojit Paul,et al.  Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies , 2020, Experimental Neurology.

[17]  M. Huang,et al.  Inhibition of Caspase-1 Ameliorates Ischemia-Associated Blood-Brain Barrier Dysfunction and Integrity by Suppressing Pyroptosis Activation , 2021, Frontiers in Cellular Neuroscience.

[18]  John H. Zhang,et al.  Natural medicine in neuroprotection for ischemic stroke: Challenges and prospective. , 2020, Pharmacology & therapeutics.

[19]  F. Rincon,et al.  Management of Acute Ischemic Stroke , 2020, Critical care medicine.

[20]  R. Rodrigo,et al.  Pathophysiology of ischemic stroke: role of oxidative stress. , 2020, Current pharmaceutical design.

[21]  Lei He,et al.  Idebenone attenuates cerebral inflammatory injury in ischemia and reperfusion via dampening NLRP3 inflammasome activity. , 2020, Molecular immunology.

[22]  G. Hankey,et al.  Primary and Secondary Prevention of Ischemic Stroke and Cerebral Hemorrhage: JACC Focus Seminar. , 2020, Journal of the American College of Cardiology.

[23]  Xia Li,et al.  Adiponectin peptide alleviates oxidative stress and NLRP3 inflammasome activation after cerebral ischemia-reperfusion injury by regulating AMPK/GSK-3β , 2020, Experimental Neurology.

[24]  R. Nogueira,et al.  Endovascular Treatment of Acute Ischemic Stroke. , 2020, Continuum.

[25]  A. Rabinstein.  Update on Treatment of Acute Ischemic Stroke. , 2020, Continuum.

[26]  Z. Pei,et al.  Extracellular ASC exacerbated the recurrent ischemic stroke in an NLRP3-dependent manner , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  X. Xiong,et al.  Meisoindigo Protects Against Focal Cerebral Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation and Regulating Microglia/Macrophage Polarization via TLR4/NF-κB Signaling Pathway , 2019, Front. Cell. Neurosci..

[28]  S. Johnston,et al.  Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. , 2019, JAMA neurology.

[29]  T. Jin,et al.  Pharmacological Inhibitors of the NLRP3 Inflammasome , 2019, Front. Immunol..

[30]  Z. Xia,et al.  Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome , 2019, Cell Death & Disease.

[31]  Yuan He,et al.  The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation , 2019, International journal of molecular sciences.

[32]  Yuan Yao,et al.  Prostaglandin E2 Regulates Activation of Mouse Peritoneal Macrophages by Staphylococcus aureus through Toll-Like Receptor 2, Toll-Like Receptor 4, and NLRP3 Inflammasome Signaling , 2019, Journal of Innate Immunity.

[33]  S. Khoshnam,et al.  NLRP3 inflammasome in ischemic stroke: As possible therapeutic target , 2019, International journal of stroke : official journal of the International Stroke Society.

[34]  C. Reis,et al.  NLRP3 Inflammasome in the Pathophysiology of Hemorrhagic Stroke: A Review , 2019, Current neuropharmacology.

[35]  G. Dubyak,et al.  TLR-stimulated IRAKM activates caspase-8 inflammasome in microglia and promotes neuroinflammation , 2018, The Journal of clinical investigation.

[36]  Ying Peng,et al.  Mitochondrial dysfunction induces NLRP3 inflammasome activation during cerebral ischemia/reperfusion injury , 2018, Journal of Neuroinflammation.

[37]  M. Tymianski,et al.  Neurotransmitters in the mediation of cerebral ischemic injury , 2017, Neuropharmacology.

[38]  R. Deshaies,et al.  Thiolutin is a zinc chelator that inhibits the Rpn11 and other JAMM metalloproteases. , 2017, Nature chemical biology.

[39]  Jing Qiu,et al.  The neuroprotection of Sinomenine against ischemic stroke in mice by suppressing NLRP3 inflammasome via AMPK signaling. , 2016, International immunopharmacology.

[40]  Yi-Zun Yu,et al.  Dithiolopyrrolone Natural Products: Isolation, Synthesis and Biosynthesis , 2013, Marine drugs.

[41]  Junying Yuan,et al.  Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. , 2013, Molecular cell.

[42]  D. Wink,et al.  Thiolutin inhibits endothelial cell adhesion by perturbing Hsp27 interactions with components of the actin and intermediate filament cytoskeleton , 2010, Cell Stress and Chaperones.

[43]  M. Kawada,et al.  Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell‐induced angiogenesis , 2001, International journal of cancer.